Arthur T. Sands

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NRIX

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Nurix Therapeutics, Inc. (NRIX)	President, Chief Executive Officer and Director	$674,584	—	—	$5,166,196	$510,000	$23,358	$6,374,138
2024	Nurix Therapeutics, Inc. (NRIX)	President, Chief Executive Officer and Director	$613,104	—	—	$4,751,716	$424,350	$23,692	$5,812,862
2023	Nurix Therapeutics, Inc. (NRIX)	President, Chief Executive Officer and Director	$590,813	—	—	$3,376,799	$355,350	$40,158	$4,363,120
2022	Nurix Therapeutics, Inc. (NRIX)	President, Chief Executive Officer and Director	$572,083	—	—	$8,505,239	$293,250	$45,649	$9,416,222
2021	Nurix Therapeutics, Inc. (NRIX)	M.D., Ph.D. President, Chief Executive Officer and Director	$538,750	—	—	$3,948,993	$297,000	$6,723	$4,791,466
2020	Nurix Therapeutics, Inc. (NRIX)	M.D., Ph.D. President, Chief Executive Officer and Director	$521,167	—	—	$16,015,074	$328,100	$3,500	$16,867,841
2019	Nurix Therapeutics, Inc. (NRIX)	M.D., Ph.D. President, Chief Executive Officer and Director	$477,833	$400,000	—	$352,265	—	$251,512	$1,481,610

No earnings-call appearances or filed executive changes recorded yet.